New drugs (FDA record)

Every new-molecule drug the FDA approved, by date, at the company that made it. 981 points on the WW9 Atlas, oldest first, each with its source.

Open this layer on the map

Pages: 1 2 3

• Tubocurarine Chloride (tubocurarine chloride)1945 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1945-02-20. Active ingredient: tubocurarine chloride. Sponsor: Bristol Myers Squibb. Application NDA005657.FDA Drugs@FDA, application NDA005657 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005657)
• Benadryl (diphenhydramine hydrochloride)1946 · FDA new drug approval · McNeil Consumer Healthcare headquarters, Fort WashingtonNew drug approved by the FDA on 1946-03-04. Active ingredient: diphenhydramine hydrochloride. Sponsor: Mcneil Cons. Application NDA005845.FDA Drugs@FDA, application NDA005845 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005845)
• Decapryn (doxylamine succinate)1948 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1948-04-07. Active ingredient: doxylamine succinate. Sponsor: Sanofi Aventis Us. Application NDA006412.FDA Drugs@FDA, application NDA006412 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006412)
• Pbz (tripelennamine citrate, tripelennamine hydrochloride)1948 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1948-02-19. Active ingredient: tripelennamine citrate, tripelennamine hydrochloride. Sponsor: Novartis. Application NDA005914.FDA Drugs@FDA, application NDA005914 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005914)
• Metubine Iodide (metocurine iodide)1949 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1949-01-04. Active ingredient: metocurine iodide. Sponsor: Lilly. Application NDA006632.FDA Drugs@FDA, application NDA006632 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006632)
• Acthar (corticotropin)1950 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1950-07-03. Active ingredient: corticotropin. Sponsor: Sanofi Aventis Us. Application NDA007504.FDA Drugs@FDA, application NDA007504 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007504)
• Azulfidine En-Tabs (sulfasalazine)1950 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1950-06-20. Active ingredient: sulfasalazine. Sponsor: Pfizer. Application NDA007073.FDA Drugs@FDA, application NDA007073 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007073)
• Bentyl (dicyclomine hydrochloride)1950 · FDA new drug approval · Allergan plc headquarters, IrelandNew drug approved by the FDA on 1950-05-11. Active ingredient: dicyclomine hydrochloride. Sponsor: Allergan. Application NDA007409.FDA Drugs@FDA, application NDA007409 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007409)
• Cortone (cortisone acetate)1950 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1950-06-13. Active ingredient: cortisone acetate. Sponsor: Merck. Application NDA007110.FDA Drugs@FDA, application NDA007110 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007110)
• Levophed (norepinephrine bitartrate)1950 · FDA new drug approval · Hospira headquarters, Lake ForestNew drug approved by the FDA on 1950-07-13. Active ingredient: norepinephrine bitartrate. Sponsor: Hospira. Application NDA007513.FDA Drugs@FDA, application NDA007513 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007513)
• Banthine (methantheline bromide)1951 · FDA new drug approval · Shire plc headquarters, BasingstokeNew drug approved by the FDA on 1951-07-03. Active ingredient: methantheline bromide. Sponsor: Shire. Application NDA007390.FDA Drugs@FDA, application NDA007390 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007390)
• Benemid (probenecid)1951 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1951-04-26. Active ingredient: probenecid. Sponsor: Merck. Application NDA007898.FDA Drugs@FDA, application NDA007898 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007898)
• Phenurone (phenacemide)1951 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1951-06-28. Active ingredient: phenacemide. Sponsor: Abbvie. Application NDA007707.FDA Drugs@FDA, application NDA007707 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007707)
• Telepaque (iopanoic acid)1951 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1951-07-16. Active ingredient: iopanoic acid. Sponsor: Ge Healthcare. Application NDA008032.FDA Drugs@FDA, application NDA008032 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008032)
• Anectine (succinylcholine chloride)1952 · FDA new drug approval · Sandoz headquarters, BaselNew drug approved by the FDA on 1952-08-20. Active ingredient: succinylcholine chloride. Sponsor: Sandoz. Application NDA008453.FDA Drugs@FDA, application NDA008453 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008453)
• Leucovorin Calcium (leucovorin calcium)1952 · FDA new drug approval · Hospira headquarters, Lake ForestNew drug approved by the FDA on 1952-06-20. Active ingredient: leucovorin calcium. Sponsor: Hospira. Application NDA008107.FDA Drugs@FDA, application NDA008107 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008107)
• Regitine (phentolamine mesylate)1952 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1952-01-30. Active ingredient: phentolamine mesylate. Sponsor: Novartis. Application NDA008278.FDA Drugs@FDA, application NDA008278 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008278)
• Apresoline (hydralazine hydrochloride)1953 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1953-01-15. Active ingredient: hydralazine hydrochloride. Sponsor: Novartis. Application NDA008303.FDA Drugs@FDA, application NDA008303 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008303)
• Calcium Disodium Versenate (edetate calcium disodium)1953 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1953-07-16. Active ingredient: edetate calcium disodium. Sponsor: Bausch. Application NDA008922.FDA Drugs@FDA, application NDA008922 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008922)
• Diamox (acetazolamide)1953 · FDA new drug approval · Teva Pharmaceutical Industries Ltd. headquarters, Ramat HaHayalNew drug approved by the FDA on 1953-07-27. Active ingredient: acetazolamide. Sponsor: Teva Branded Pharm. Application NDA008943.FDA Drugs@FDA, application NDA008943 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008943)
• Furadantin (nitrofurantoin)1953 · FDA new drug approval · Procter & Gamble headquarters, CincinnatiNew drug approved by the FDA on 1953-02-06. Active ingredient: nitrofurantoin. Sponsor: Procter And Gamble. Application NDA008693.FDA Drugs@FDA, application NDA008693 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008693)
• Hydergine (ergoloid mesylates)1953 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1953-11-05. Active ingredient: ergoloid mesylates. Sponsor: Novartis. Application NDA009087.FDA Drugs@FDA, application NDA009087 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009087)
• Pagitane (cycrimine hydrochloride)1953 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1953-07-22. Active ingredient: cycrimine hydrochloride. Sponsor: Lilly. Application NDA008951.FDA Drugs@FDA, application NDA008951 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008951)
• Pro-Banthine (propantheline bromide)1953 · FDA new drug approval · Shire plc headquarters, BasingstokeNew drug approved by the FDA on 1953-04-02. Active ingredient: propantheline bromide. Sponsor: Shire. Application NDA008732.FDA Drugs@FDA, application NDA008732 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008732)
• Cogentin (benztropine mesylate)1954 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1954-03-05. Active ingredient: benztropine mesylate. Sponsor: Merck. Application NDA009193.FDA Drugs@FDA, application NDA009193 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009193)
• Coumadin (warfarin sodium)1954 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1954-06-08. Active ingredient: warfarin sodium. Sponsor: Bristol Myers Squibb. Application NDA009218.FDA Drugs@FDA, application NDA009218 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009218)
• Hypaque Sodium 20% (diatrizoate sodium)1954 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1954-11-26. Active ingredient: diatrizoate sodium. Sponsor: Ge Healthcare. Application NDA009561.FDA Drugs@FDA, application NDA009561 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009561)
• Lipiodol (ethiodized oil)1954 · FDA new drug approval · Guerbet headquarters, VillepinteNew drug approved by the FDA on 1954-03-31. Active ingredient: ethiodized oil. Sponsor: Guerbet. Application NDA009190.FDA Drugs@FDA, application NDA009190 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009190)
• Lotusate (talbutal)1954 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1954-09-21. Active ingredient: talbutal. Sponsor: Sanofi Aventis Us. Application NDA009410.FDA Drugs@FDA, application NDA009410 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009410)
• Mysoline (primidone)1954 · FDA new drug approval · Bausch Health headquarters, LavalNew drug approved by the FDA on 1954-03-08. Active ingredient: primidone. Sponsor: Valeant. Application NDA009170.FDA Drugs@FDA, application NDA009170 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009170)
• Mestinon (pyridostigmine bromide)1955 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1955-04-06. Active ingredient: pyridostigmine bromide. Sponsor: Bausch. Application NDA009829.FDA Drugs@FDA, application NDA009829 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009829)
• Meticorten (prednisone)1955 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1955-02-21. Active ingredient: prednisone. Sponsor: Schering. Application NDA009766.FDA Drugs@FDA, application NDA009766 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009766)
• Nesacaine-Mpf (chloroprocaine hydrochloride)1955 · FDA new drug approval · Fresenius Kabi headquarters, Bad Homburg vor der HöheNew drug approved by the FDA on 1955-03-11. Active ingredient: chloroprocaine hydrochloride. Sponsor: Fresenius Kabi Usa. Application NDA009435.FDA Drugs@FDA, application NDA009435 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009435)
• Atarax (hydroxyzine hydrochloride)1956 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1956-04-12. Active ingredient: hydroxyzine hydrochloride. Sponsor: Pfizer. Application NDA010392.FDA Drugs@FDA, application NDA010392 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010392)
• Cantil (mepenzolate bromide)1956 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1956-11-14. Active ingredient: mepenzolate bromide. Sponsor: Sanofi Aventis Us. Application NDA010679.FDA Drugs@FDA, application NDA010679 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010679)
• Compazine (prochlorperazine maleate)1956 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1956-10-23. Active ingredient: prochlorperazine maleate. Sponsor: Glaxosmithkline. Application NDA010571.FDA Drugs@FDA, application NDA010571 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010571)
• Magnacort (hydrocortamate hydrochloride)1956 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1956-10-15. Active ingredient: hydrocortamate hydrochloride. Sponsor: Pfizer. Application NDA010554.FDA Drugs@FDA, application NDA010554 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010554)
• Mytelase (ambenonium chloride)1956 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1956-05-01. Active ingredient: ambenonium chloride. Sponsor: Sanofi Aventis Us. Application NDA010155.FDA Drugs@FDA, application NDA010155 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010155)
• Sparine (promazine hydrochloride)1956 · FDA new drug approval · Hikma Pharmaceuticals headquarters, LondonNew drug approved by the FDA on 1956-04-13. Active ingredient: promazine hydrochloride. Sponsor: Hikma. Application NDA010349.FDA Drugs@FDA, application NDA010349 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010349)
• Aristocort (triamcinolone)1957 · FDA new drug approval · Astellas Pharma headquarters, ChūōNew drug approved by the FDA on 1957-12-03. Active ingredient: triamcinolone. Sponsor: Astellas. Application NDA011161.FDA Drugs@FDA, application NDA011161 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011161)
• Doriden (glutethimide)1957 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1957-04-16. Active ingredient: glutethimide. Sponsor: Sanofi Aventis Us. Application NDA009519.FDA Drugs@FDA, application NDA009519 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009519)
• Harmonyl (deserpidine)1957 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1957-04-19. Active ingredient: deserpidine. Sponsor: Abbvie. Application NDA010796.FDA Drugs@FDA, application NDA010796 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010796)
• Leritine (anileridine hydrochloride)1957 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1957-08-15. Active ingredient: anileridine hydrochloride. Sponsor: Merck. Application NDA010585.FDA Drugs@FDA, application NDA010585 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010585)
• Medrol (methylprednisolone)1957 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1957-10-24. Active ingredient: methylprednisolone. Sponsor: Pfizer. Application NDA011153.FDA Drugs@FDA, application NDA011153 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011153)
• Miradon (anisindione)1957 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1957-04-05. Active ingredient: anisindione. Sponsor: Schering. Application NDA010909.FDA Drugs@FDA, application NDA010909 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010909)
• Thorazine (chlorpromazine, chlorpromazine hydrochloride)1957 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1957-11-20. Active ingredient: chlorpromazine, chlorpromazine hydrochloride. Sponsor: Glaxosmithkline. Application NDA009149.FDA Drugs@FDA, application NDA009149 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009149)
• Tral (hexocyclium methylsulfate)1957 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1957-02-13. Active ingredient: hexocyclium methylsulfate. Sponsor: Abbvie. Application NDA010599.FDA Drugs@FDA, application NDA010599 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010599)
• Trilafon (perphenazine)1957 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1957-02-27. Active ingredient: perphenazine. Sponsor: Schering. Application NDA010775.FDA Drugs@FDA, application NDA010775 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010775)
• Vesprin (triflupromazine hydrochloride)1957 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1957-09-16. Active ingredient: triflupromazine hydrochloride. Sponsor: Bristol Myers Squibb. Application NDA011123.FDA Drugs@FDA, application NDA011123 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011123)
• Decadron (dexamethasone)1958 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1958-10-30. Active ingredient: dexamethasone. Sponsor: Merck. Application NDA011664.FDA Drugs@FDA, application NDA011664 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011664)
• Diabinese (chlorpropamide)1958 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1958-10-28. Active ingredient: chlorpropamide. Sponsor: Pfizer. Application NDA011641.FDA Drugs@FDA, application NDA011641 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011641)
• Keveyis (dichlorphenamide)1958 · FDA new drug approval · Xeris Pharmaceuticals (United States) headquarters, AustinNew drug approved by the FDA on 1958-07-22. Active ingredient: dichlorphenamide. Sponsor: Xeris. Application NDA011366.FDA Drugs@FDA, application NDA011366 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011366)
• Tessalon (benzonatate)1958 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1958-02-10. Active ingredient: benzonatate. Sponsor: Pfizer. Application NDA011210.FDA Drugs@FDA, application NDA011210 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011210)
• Akineton (biperiden hydrochloride)1959 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1959-09-08. Active ingredient: biperiden hydrochloride. Sponsor: Abbvie. Application NDA012003.FDA Drugs@FDA, application NDA012003 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012003)
• Anturane (sulfinpyrazone)1959 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1959-05-13. Active ingredient: sulfinpyrazone. Sponsor: Novartis. Application NDA011556.FDA Drugs@FDA, application NDA011556 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011556)
• Durabolin (nandrolone phenpropionate)1959 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1959-10-30. Active ingredient: nandrolone phenpropionate. Sponsor: Organon Usa Inc. Application NDA011891.FDA Drugs@FDA, application NDA011891 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011891)
• Esidrix (hydrochlorothiazide)1959 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1959-02-12. Active ingredient: hydrochlorothiazide. Sponsor: Novartis. Application NDA011793.FDA Drugs@FDA, application NDA011793 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011793)
• Humorsol (demecarium bromide)1959 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1959-08-05. Active ingredient: demecarium bromide. Sponsor: Merck. Application NDA011860.FDA Drugs@FDA, application NDA011860 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011860)
• Ionamin (phentermine resin complex)1959 · FDA new drug approval · UCB headquarters, Brussels metropolitan areaNew drug approved by the FDA on 1959-05-04. Active ingredient: phentermine resin complex. Sponsor: Ucb Inc. Application NDA011613.FDA Drugs@FDA, application NDA011613 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011613)
• Isordil (isosorbide dinitrate)1959 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1959-11-09. Active ingredient: isosorbide dinitrate. Sponsor: Bausch. Application NDA012093.FDA Drugs@FDA, application NDA012093 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012093)
• Pentothal (thiopental sodium)1959 · FDA new drug approval · Abbott Laboratories headquarters, North ChicagoNew drug approved by the FDA on 1959-09-23. Active ingredient: thiopental sodium. Sponsor: Abbott. Application NDA011679.FDA Drugs@FDA, application NDA011679 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011679)
• Permitil (fluphenazine hydrochloride)1959 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1959-09-09. Active ingredient: fluphenazine hydrochloride. Sponsor: Schering. Application NDA012034.FDA Drugs@FDA, application NDA012034 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012034)
• Presamine (imipramine hydrochloride)1959 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1959-04-16. Active ingredient: imipramine hydrochloride. Sponsor: Sanofi Aventis Us. Application NDA011836.FDA Drugs@FDA, application NDA011836 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011836)
• Provera (medroxyprogesterone acetate)1959 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1959-06-18. Active ingredient: medroxyprogesterone acetate. Sponsor: Pfizer. Application NDA011839.FDA Drugs@FDA, application NDA011839 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011839)
• Saluron (hydroflumethiazide)1959 · FDA new drug approval · Shire plc headquarters, BasingstokeNew drug approved by the FDA on 1959-07-22. Active ingredient: hydroflumethiazide. Sponsor: Shire Llc. Application NDA011949.FDA Drugs@FDA, application NDA011949 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011949)
• Stelazine (trifluoperazine hydrochloride)1959 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1959-04-16. Active ingredient: trifluoperazine hydrochloride. Sponsor: Glaxosmithkline. Application NDA011552.FDA Drugs@FDA, application NDA011552 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011552)
• Thiotepa (thiotepa)1959 · FDA new drug approval · ImmuneXcite (United States) headquarters, LexingtonNew drug approved by the FDA on 1959-03-09. Active ingredient: thiotepa. Sponsor: Immunex. Application NDA011683.FDA Drugs@FDA, application NDA011683 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011683)
• Aldactone (spironolactone)1960 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1960-01-21. Active ingredient: spironolactone. Sponsor: Pfizer. Application NDA012151.FDA Drugs@FDA, application NDA012151 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012151)
• Didrex (benzphetamine hydrochloride)1960 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1960-10-26. Active ingredient: benzphetamine hydrochloride. Sponsor: Pfizer. Application NDA012427.FDA Drugs@FDA, application NDA012427 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012427)
• Enduron (methyclothiazide)1960 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1960-10-21. Active ingredient: methyclothiazide. Sponsor: Abbvie. Application NDA012524.FDA Drugs@FDA, application NDA012524 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012524)
• Glucagon (glucagon hydrochloride)1960 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1960-11-14. Active ingredient: glucagon hydrochloride. Sponsor: Lilly. Application NDA012122.FDA Drugs@FDA, application NDA012122 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012122)
• Hygroton (chlorthalidone)1960 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1960-04-07. Active ingredient: chlorthalidone. Sponsor: Sanofi Aventis Us. Application NDA012283.FDA Drugs@FDA, application NDA012283 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012283)
• Ismelin (guanethidine monosulfate)1960 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1960-07-05. Active ingredient: guanethidine monosulfate. Sponsor: Novartis. Application NDA012329.FDA Drugs@FDA, application NDA012329 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012329)
• Largon (propiomazine hydrochloride)1960 · FDA new drug approval · Hikma Pharmaceuticals headquarters, LondonNew drug approved by the FDA on 1960-12-05. Active ingredient: propiomazine hydrochloride. Sponsor: Hikma. Application NDA012382.FDA Drugs@FDA, application NDA012382 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012382)
• Mydriacyl (tropicamide)1960 · FDA new drug approval · Alcon headquarters, GenevaNew drug approved by the FDA on 1960-02-23. Active ingredient: tropicamide. Sponsor: Alcon. Application NDA012111.FDA Drugs@FDA, application NDA012111 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012111)
• Naquival (reserpine, trichlormethiazide)1960 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1960-03-09. Active ingredient: reserpine, trichlormethiazide. Sponsor: Schering. Application NDA012265.FDA Drugs@FDA, application NDA012265 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012265)
• Tandearil (oxyphenbutazone)1960 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1960-12-21. Active ingredient: oxyphenbutazone. Sponsor: Novartis. Application NDA012542.FDA Drugs@FDA, application NDA012542 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012542)
• Trancopal (chlormezanone)1960 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1960-05-20. Active ingredient: chlormezanone. Sponsor: Sanofi Aventis Us. Application NDA011467.FDA Drugs@FDA, application NDA011467 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011467)
• Celestone (betamethasone)1961 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1961-04-17. Active ingredient: betamethasone. Sponsor: Schering. Application NDA012657.FDA Drugs@FDA, application NDA012657 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012657)
• Elavil (amitriptyline hydrochloride)1961 · FDA new drug approval · AstraZeneca headquarters, CambridgeNew drug approved by the FDA on 1961-04-07. Active ingredient: amitriptyline hydrochloride. Sponsor: Astrazeneca. Application NDA012703.FDA Drugs@FDA, application NDA012703 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012703)
• Haldrone (paramethasone acetate)1961 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1961-04-17. Active ingredient: paramethasone acetate. Sponsor: Lilly. Application NDA012772.FDA Drugs@FDA, application NDA012772 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012772)
• Periactin (cyproheptadine hydrochloride)1961 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1961-10-17. Active ingredient: cyproheptadine hydrochloride. Sponsor: Merck. Application NDA012649.FDA Drugs@FDA, application NDA012649 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012649)
• Persantine (dipyridamole)1961 · FDA new drug approval · Boehringer Ingelheim headquarters, Ingelheim am RheinNew drug approved by the FDA on 1961-12-06. Active ingredient: dipyridamole. Sponsor: Boehringer Ingelheim. Application NDA012836.FDA Drugs@FDA, application NDA012836 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012836)
• Renese (polythiazide)1961 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1961-09-26. Active ingredient: polythiazide. Sponsor: Pfizer. Application NDA012845.FDA Drugs@FDA, application NDA012845 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012845)
• Tindal (acetophenazine maleate)1961 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1961-04-05. Active ingredient: acetophenazine maleate. Sponsor: Schering. Application NDA012254.FDA Drugs@FDA, application NDA012254 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012254)
• Torecan (thiethylperazine maleate)1961 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1961-07-18. Active ingredient: thiethylperazine maleate. Sponsor: Novartis. Application NDA012753.FDA Drugs@FDA, application NDA012753 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012753)
• Aldomet (methyldopa)1962 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1962-12-20. Active ingredient: methyldopa. Sponsor: Merck. Application NDA013400.FDA Drugs@FDA, application NDA013400 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013400)
• Mellaril (thioridazine hydrochloride)1962 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1962-03-15. Active ingredient: thioridazine hydrochloride. Sponsor: Novartis. Application NDA011808.FDA Drugs@FDA, application NDA011808 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011808)
• Penthrane (methoxyflurane)1962 · FDA new drug approval · Abbott Laboratories headquarters, North ChicagoNew drug approved by the FDA on 1962-05-04. Active ingredient: methoxyflurane. Sponsor: Abbott. Application NDA013056.FDA Drugs@FDA, application NDA013056 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013056)
• Sansert (methysergide maleate)1962 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1962-02-12. Active ingredient: methysergide maleate. Sponsor: Novartis. Application NDA012516.FDA Drugs@FDA, application NDA012516 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012516)
• Uracil Mustard (uracil mustard)1962 · FDA new drug approval · Shire plc headquarters, BasingstokeNew drug approved by the FDA on 1962-09-13. Active ingredient: uracil mustard. Sponsor: Shire. Application NDA012892.FDA Drugs@FDA, application NDA012892 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012892)
• Winstrol (stanozolol)1962 · FDA new drug approval · Lundbeck headquarters, ValbyNew drug approved by the FDA on 1962-01-09. Active ingredient: stanozolol. Sponsor: Lundbeck Inc. Application NDA012885.FDA Drugs@FDA, application NDA012885 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012885)
• Anhydron (cyclothiazide)1963 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1963-08-20. Active ingredient: cyclothiazide. Sponsor: Lilly. Application NDA013157.FDA Drugs@FDA, application NDA013157 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013157)
• Flagyl (metronidazole)1963 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1963-07-18. Active ingredient: metronidazole. Sponsor: Pfizer. Application NDA012623.FDA Drugs@FDA, application NDA012623 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012623)
• Herplex (idoxuridine)1963 · FDA new drug approval · Allergan plc headquarters, IrelandNew drug approved by the FDA on 1963-06-11. Active ingredient: idoxuridine. Sponsor: Allergan. Application NDA013935.FDA Drugs@FDA, application NDA013935 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013935)
• Oncovin (vincristine sulfate)1963 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1963-07-10. Active ingredient: vincristine sulfate. Sponsor: Lilly. Application NDA014103.FDA Drugs@FDA, application NDA014103 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014103)
• Synalar (fluocinolone acetonide)1963 · FDA new drug approval · Eurofarma headquarters, São PauloNew drug approved by the FDA on 1963-02-15. Active ingredient: fluocinolone acetonide. Sponsor: Eurofarma. Application NDA012787.FDA Drugs@FDA, application NDA012787 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012787)
• Alkeran (melphalan)1964 · FDA new drug approval · Apotex headquarters, TorontoNew drug approved by the FDA on 1964-01-17. Active ingredient: melphalan. Sponsor: Apotex. Application NDA014691.FDA Drugs@FDA, application NDA014691 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014691)
• Amicar (aminocaproic acid)1964 · FDA new drug approval · Hikma Pharmaceuticals headquarters, LondonNew drug approved by the FDA on 1964-06-03. Active ingredient: aminocaproic acid. Sponsor: Hikma. Application NDA015197.FDA Drugs@FDA, application NDA015197 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=015197)
• Aventyl Hydrochloride (nortriptyline hydrochloride)1964 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1964-11-06. Active ingredient: nortriptyline hydrochloride. Sponsor: Lilly. Application NDA014684.FDA Drugs@FDA, application NDA014684 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014684)
• Dymelor (acetohexamide)1964 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1964-12-23. Active ingredient: acetohexamide. Sponsor: Lilly. Application NDA013378.FDA Drugs@FDA, application NDA013378 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013378)
• Maxibolin (ethylestrenol)1964 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1964-05-28. Active ingredient: ethylestrenol. Sponsor: Organon Usa Inc. Application NDA014005.FDA Drugs@FDA, application NDA014005 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014005)
• Neggram (nalidixic acid)1964 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1964-03-06. Active ingredient: nalidixic acid. Sponsor: Sanofi Aventis Us. Application NDA014214.FDA Drugs@FDA, application NDA014214 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014214)
• Celestone Soluspan (betamethasone acetate, betamethasone sodium phosphate)1965 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1965-03-03. Active ingredient: betamethasone acetate, betamethasone sodium phosphate. Sponsor: Organon. Application NDA014602.FDA Drugs@FDA, application NDA014602 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014602)
• Citanest Plain (epinephrine bitartrate, prilocaine hydrochloride)1965 · FDA new drug approval · AstraZeneca headquarters, CambridgeNew drug approved by the FDA on 1965-11-18. Active ingredient: epinephrine bitartrate, prilocaine hydrochloride. Sponsor: Astrazeneca. Application NDA014763.FDA Drugs@FDA, application NDA014763 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014763)
• Dopram (doxapram hydrochloride)1965 · FDA new drug approval · Hikma Pharmaceuticals headquarters, LondonNew drug approved by the FDA on 1965-06-23. Active ingredient: doxapram hydrochloride. Sponsor: Hikma. Application NDA014879.FDA Drugs@FDA, application NDA014879 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014879)
• Santyl (collagenase)1965 · FDA new drug approval · Smith & Nephew headquarters, LondonNew drug approved by the FDA on 1965-06-04. Active ingredient: collagenase. Sponsor: Smith And Nephew. Application BLA101995.FDA Drugs@FDA, application BLA101995 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=101995)
• Velban (vinblastine sulfate)1965 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1965-11-25. Active ingredient: vinblastine sulfate. Sponsor: Lilly. Application NDA012665.FDA Drugs@FDA, application NDA012665 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012665)
• Vercyte (pipobroman)1966 · FDA new drug approval · Abbott Laboratories headquarters, North ChicagoNew drug approved by the FDA on 1966-07-01. Active ingredient: pipobroman. Sponsor: Abbott. Application NDA016245.FDA Drugs@FDA, application NDA016245 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016245)
• Clomid (clomiphene citrate)1967 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1967-02-01. Active ingredient: clomiphene citrate. Sponsor: Sanofi Aventis Us. Application NDA016131.FDA Drugs@FDA, application NDA016131 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016131)
• Edecrin (ethacrynic acid)1967 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1967-01-10. Active ingredient: ethacrynic acid. Sponsor: Bausch. Application NDA016092.FDA Drugs@FDA, application NDA016092 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016092)
• Mintezol (thiabendazole)1967 · FDA new drug approval · Merck & Co. headquarters, KenilworthNew drug approved by the FDA on 1967-04-07. Active ingredient: thiabendazole. Sponsor: Merck Sharp Dohme. Application NDA016096.FDA Drugs@FDA, application NDA016096 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016096)
• Navane (thiothixene)1967 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1967-07-24. Active ingredient: thiothixene. Sponsor: Pfizer. Application NDA016584.FDA Drugs@FDA, application NDA016584 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016584)
• Talwin (pentazocine lactate)1967 · FDA new drug approval · Hospira headquarters, Lake ForestNew drug approved by the FDA on 1967-07-24. Active ingredient: pentazocine lactate. Sponsor: Hospira. Application NDA016194.FDA Drugs@FDA, application NDA016194 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016194)
• Vontrol (diphenidol hydrochloride)1967 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1967-04-05. Active ingredient: diphenidol hydrochloride. Sponsor: Glaxosmithkline. Application NDA016033.FDA Drugs@FDA, application NDA016033 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016033)
• Tegretol (carbamazepine)1968 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1968-03-11. Active ingredient: carbamazepine. Sponsor: Novartis. Application NDA016608.FDA Drugs@FDA, application NDA016608 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016608)
• Bilopaque (tyropanoate sodium)1969 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1969-10-24. Active ingredient: tyropanoate sodium. Sponsor: Ge Healthcare. Application NDA013731.FDA Drugs@FDA, application NDA013731 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013731)
• Hms (medrysone)1969 · FDA new drug approval · Allergan plc headquarters, IrelandNew drug approved by the FDA on 1969-11-28. Active ingredient: medrysone. Sponsor: Allergan. Application NDA016624.FDA Drugs@FDA, application NDA016624 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016624)
• Sinequan (doxepin hydrochloride)1969 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1969-09-23. Active ingredient: doxepin hydrochloride. Sponsor: Pfizer. Application NDA016798.FDA Drugs@FDA, application NDA016798 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016798)
• Teslac (testolactone)1969 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1969-06-03. Active ingredient: testolactone. Sponsor: Bristol Myers Squibb. Application NDA016119.FDA Drugs@FDA, application NDA016119 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016119)
• Travase (sutilains)1969 · FDA new drug approval · Abbott Laboratories headquarters, North ChicagoNew drug approved by the FDA on 1969-06-12. Active ingredient: sutilains. Sponsor: Abbott. Application NDA012828.FDA Drugs@FDA, application NDA012828 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012828)
• Fudr (floxuridine)1970 · FDA new drug approval · Hospira headquarters, Lake ForestNew drug approved by the FDA on 1970-12-18. Active ingredient: floxuridine. Sponsor: Hospira. Application NDA016929.FDA Drugs@FDA, application NDA016929 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016929)
• Lithonate (lithium carbonate)1970 · FDA new drug approval · Solvay S.A. headquarters, BrusselsNew drug approved by the FDA on 1970-04-06. Active ingredient: lithium carbonate. Sponsor: Solvay. Application NDA016782.FDA Drugs@FDA, application NDA016782 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016782)
• Mithracin (plicamycin)1970 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1970-05-05. Active ingredient: plicamycin. Sponsor: Pfizer. Application NDA050109.FDA Drugs@FDA, application NDA050109 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050109)
• Serentil (mesoridazine besylate)1970 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1970-02-27. Active ingredient: mesoridazine besylate. Sponsor: Novartis. Application NDA016774.FDA Drugs@FDA, application NDA016774 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016774)
• Ancobon (flucytosine)1971 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1971-11-26. Active ingredient: flucytosine. Sponsor: Bausch. Application NDA017001.FDA Drugs@FDA, application NDA017001 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017001)
• Megace (megestrol acetate)1971 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1971-08-18. Active ingredient: megestrol acetate. Sponsor: Bristol Myers Squibb. Application NDA016979.FDA Drugs@FDA, application NDA016979 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016979)
• Fluorine F-18 (sodium fluoride f-18)1972 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1972-02-24. Active ingredient: sodium fluoride f-18. Sponsor: Ge Healthcare. Application NDA017042.FDA Drugs@FDA, application NDA017042 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017042)
• Marcaine Hydrochloride W/ Epinephrine Preservative Free (bupivacaine hydrochloride, epinephrine bitartrate)1972 · FDA new drug approval · Hospira headquarters, Lake ForestNew drug approved by the FDA on 1972-10-03. Active ingredient: bupivacaine hydrochloride, epinephrine bitartrate. Sponsor: Hospira. Application NDA016964.FDA Drugs@FDA, application NDA016964 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016964)
• Miostat (carbachol)1972 · FDA new drug approval · Alcon headquarters, GenevaNew drug approved by the FDA on 1972-09-28. Active ingredient: carbachol. Sponsor: Alcon. Application NDA016968.FDA Drugs@FDA, application NDA016968 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016968)
• Pavulon (pancuronium bromide)1972 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1972-10-24. Active ingredient: pancuronium bromide. Sponsor: Organon Usa Inc. Application NDA017015.FDA Drugs@FDA, application NDA017015 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017015)
• Alupent (metaproterenol sulfate)1973 · FDA new drug approval · Boehringer Ingelheim headquarters, Ingelheim am RheinNew drug approved by the FDA on 1973-07-31. Active ingredient: metaproterenol sulfate. Sponsor: Boehringer Ingelheim. Application NDA016402.FDA Drugs@FDA, application NDA016402 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016402)
• Blenoxane (bleomycin sulfate)1973 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1973-07-31. Active ingredient: bleomycin sulfate. Sponsor: Bristol Myers Squibb. Application NDA050443.FDA Drugs@FDA, application NDA050443 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050443)
• Cholebrine (iocetamic acid)1973 · FDA new drug approval · Mallinckrodt Pharmaceuticals headquarters, IrelandNew drug approved by the FDA on 1973-05-16. Active ingredient: iocetamic acid. Sponsor: Mallinckrodt. Application NDA017129.FDA Drugs@FDA, application NDA017129 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017129)
• Ferrous Citrate Fe 59 (ferrous citrate, fe-59)1973 · FDA new drug approval · Mallinckrodt Pharmaceuticals headquarters, IrelandNew drug approved by the FDA on 1973-12-17. Active ingredient: ferrous citrate, fe-59. Sponsor: Mallinckrodt. Application NDA016729.FDA Drugs@FDA, application NDA016729 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016729)
• Hyperstat (diazoxide)1973 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1973-01-22. Active ingredient: diazoxide. Sponsor: Schering. Application NDA016996.FDA Drugs@FDA, application NDA016996 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016996)
• Miochol (acetylcholine chloride)1973 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1973-10-09. Active ingredient: acetylcholine chloride. Sponsor: Novartis. Application NDA016211.FDA Drugs@FDA, application NDA016211 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016211)
• Osteoscan (technetium tc-99m etidronate kit)1973 · FDA new drug approval · Mallinckrodt Pharmaceuticals headquarters, IrelandNew drug approved by the FDA on 1973-09-28. Active ingredient: technetium tc-99m etidronate kit. Sponsor: Mallinckrodt. Application NDA017454.FDA Drugs@FDA, application NDA017454 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017454)
• Sanorex (mazindol)1973 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1973-06-14. Active ingredient: mazindol. Sponsor: Novartis. Application NDA017247.FDA Drugs@FDA, application NDA017247 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017247)
• Amoxil (amoxicillin)1974 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1974-01-18. Active ingredient: amoxicillin. Sponsor: Glaxosmithkline. Application NDA050459.FDA Drugs@FDA, application NDA050459 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050459)
• Bricanyl (terbutaline sulfate)1974 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1974-03-25. Active ingredient: terbutaline sulfate. Sponsor: Sanofi Aventis Us. Application NDA017466.FDA Drugs@FDA, application NDA017466 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017466)
• Doxorubicin Hydrochloride (doxorubicin hydrochloride)1974 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1974-08-07. Active ingredient: doxorubicin hydrochloride. Sponsor: Pfizer. Application NDA050467.FDA Drugs@FDA, application NDA050467 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050467)
• Emete-Con (benzquinamide hydrochloride)1974 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1974-03-12. Active ingredient: benzquinamide hydrochloride. Sponsor: Pfizer. Application NDA016820.FDA Drugs@FDA, application NDA016820 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016820)
• Intropin (dopamine hydrochloride)1974 · FDA new drug approval · Hospira headquarters, Lake ForestNew drug approved by the FDA on 1974-02-25. Active ingredient: dopamine hydrochloride. Sponsor: Hospira. Application NDA017395.FDA Drugs@FDA, application NDA017395 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017395)
• Motrin (ibuprofen)1974 · FDA new drug approval · McNeil Consumer Healthcare headquarters, Fort WashingtonNew drug approved by the FDA on 1974-09-19. Active ingredient: ibuprofen. Sponsor: Mcneil Consumer. Application NDA017463.FDA Drugs@FDA, application NDA017463 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017463)
• Perchloracap (potassium perchlorate)1974 · FDA new drug approval · Mallinckrodt Pharmaceuticals headquarters, IrelandNew drug approved by the FDA on 1974-11-21. Active ingredient: potassium perchlorate. Sponsor: Mallinckrodt. Application NDA017551.FDA Drugs@FDA, application NDA017551 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017551)
• Cylert (pemoline)1975 · FDA new drug approval · Abbott Laboratories headquarters, North ChicagoNew drug approved by the FDA on 1975-01-27. Active ingredient: pemoline. Sponsor: Abbott. Application NDA016832.FDA Drugs@FDA, application NDA016832 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016832)
• Klonopin (clonazepam)1975 · FDA new drug approval · Cheplapharm Arzneimittel headquarters, GreifswaldNew drug approved by the FDA on 1975-06-04. Active ingredient: clonazepam. Sponsor: Cheplapharm. Application NDA017533.FDA Drugs@FDA, application NDA017533 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017533)
• Lotrimin (clotrimazole)1975 · FDA new drug approval · Schering-Plough headquarters, KenilworthNew drug approved by the FDA on 1975-02-03. Active ingredient: clotrimazole. Sponsor: Schering Plough. Application NDA017613.FDA Drugs@FDA, application NDA017613 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017613)
• Loxitane (loxapine succinate)1975 · FDA new drug approval · Teva Pharmaceutical Industries Ltd. headquarters, Ramat HaHayalNew drug approved by the FDA on 1975-02-25. Active ingredient: loxapine succinate. Sponsor: Teva Branded Pharm. Application NDA017525.FDA Drugs@FDA, application NDA017525 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017525)
• Nebcin (tobramycin sulfate)1975 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1975-06-11. Active ingredient: tobramycin sulfate. Sponsor: Lilly. Application NDA050477.FDA Drugs@FDA, application NDA050477 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050477)
• Cephulac (lactulose)1976 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1976-03-25. Active ingredient: lactulose. Sponsor: Sanofi Aventis Us. Application NDA017657.FDA Drugs@FDA, application NDA017657 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017657)
• Danocrine (danazol)1976 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1976-06-21. Active ingredient: danazol. Sponsor: Sanofi Aventis Us. Application NDA017557.FDA Drugs@FDA, application NDA017557 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017557)
• Duranest (epinephrine, epinephrine bitartrate, etidocaine hydrochloride)1976 · FDA new drug approval · AstraZeneca headquarters, CambridgeNew drug approved by the FDA on 1976-08-30. Active ingredient: epinephrine, epinephrine bitartrate, etidocaine hydrochloride. Sponsor: Astrazeneca. Application NDA017751.FDA Drugs@FDA, application NDA017751 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017751)
• Funduscein-25 (fluorescein sodium)1976 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1976-11-10. Active ingredient: fluorescein sodium. Sponsor: Novartis. Application NDA017869.FDA Drugs@FDA, application NDA017869 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017869)
• Minipress (prazosin hydrochloride)1976 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1976-06-23. Active ingredient: prazosin hydrochloride. Sponsor: Pfizer. Application NDA017442.FDA Drugs@FDA, application NDA017442 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017442)
• Sodium Iodide I 123 (sodium iodide i-123)1976 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1976-03-24. Active ingredient: sodium iodide i-123. Sponsor: Ge Healthcare. Application NDA017630.FDA Drugs@FDA, application NDA017630 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017630)
• Thypinone (protirelin)1976 · FDA new drug approval · Abbott Laboratories headquarters, North ChicagoNew drug approved by the FDA on 1976-11-05. Active ingredient: protirelin. Sponsor: Abbott. Application NDA017638.FDA Drugs@FDA, application NDA017638 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017638)
• Ticar (ticarcillin disodium)1976 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1976-11-09. Active ingredient: ticarcillin disodium. Sponsor: Glaxosmithkline. Application NDA050497.FDA Drugs@FDA, application NDA050497 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050497)
• Vanceril (beclomethasone dipropionate)1976 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1976-05-12. Active ingredient: beclomethasone dipropionate. Sponsor: Schering. Application NDA017573.FDA Drugs@FDA, application NDA017573 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017573)
• Ativan (lorazepam)1977 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1977-09-30. Active ingredient: lorazepam. Sponsor: Bausch. Application NDA017794.FDA Drugs@FDA, application NDA017794 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017794)
• Colestid (colestipol hydrochloride)1977 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1977-04-04. Active ingredient: colestipol hydrochloride. Sponsor: Pfizer. Application NDA017563.FDA Drugs@FDA, application NDA017563 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017563)
• Florone (diflorasone diacetate)1977 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1977-09-14. Active ingredient: diflorasone diacetate. Sponsor: Pfizer. Application NDA017741.FDA Drugs@FDA, application NDA017741 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017741)
• Lioresal (baclofen)1977 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1977-11-22. Active ingredient: baclofen. Sponsor: Novartis. Application NDA017851.FDA Drugs@FDA, application NDA017851 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017851)
• Lorelco (probucol)1977 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1977-02-01. Active ingredient: probucol. Sponsor: Sanofi Aventis Us. Application NDA017535.FDA Drugs@FDA, application NDA017535 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017535)
• Nolvadex (tamoxifen citrate)1977 · FDA new drug approval · AstraZeneca headquarters, CambridgeNew drug approved by the FDA on 1977-12-30. Active ingredient: tamoxifen citrate. Sponsor: Astrazeneca. Application NDA017970.FDA Drugs@FDA, application NDA017970 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017970)
• Norpace (disopyramide phosphate)1977 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1977-09-01. Active ingredient: disopyramide phosphate. Sponsor: Pfizer. Application NDA017447.FDA Drugs@FDA, application NDA017447 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017447)
• Optimine (azatadine maleate)1977 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1977-03-29. Active ingredient: azatadine maleate. Sponsor: Schering. Application NDA017601.FDA Drugs@FDA, application NDA017601 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017601)
• Prostin E2 (dinoprostone)1977 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1977-08-23. Active ingredient: dinoprostone. Sponsor: Pfizer. Application NDA017810.FDA Drugs@FDA, application NDA017810 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017810)
• Tagamet (cimetidine)1977 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1977-08-16. Active ingredient: cimetidine. Sponsor: Glaxosmithkline. Application NDA017920.FDA Drugs@FDA, application NDA017920 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017920)
• Tavist-1 (clemastine fumarate)1977 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1977-02-25. Active ingredient: clemastine fumarate. Sponsor: Novartis. Application NDA017661.FDA Drugs@FDA, application NDA017661 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017661)
• Amipaque (metrizamide)1978 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1978-08-23. Active ingredient: metrizamide. Sponsor: Ge Healthcare. Application NDA017982.FDA Drugs@FDA, application NDA017982 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017982)
• Clinoril (sulindac)1978 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1978-09-27. Active ingredient: sulindac. Sponsor: Merck. Application NDA017911.FDA Drugs@FDA, application NDA017911 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017911)
• Depakene (valproic acid)1978 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1978-02-28. Active ingredient: valproic acid. Sponsor: Abbvie. Application NDA018081.FDA Drugs@FDA, application NDA018081 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018081)
• Dobutrex (dobutamine hydrochloride)1978 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1978-07-18. Active ingredient: dobutamine hydrochloride. Sponsor: Lilly. Application NDA017820.FDA Drugs@FDA, application NDA017820 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017820)
• Duricef (cefadroxil/cefadroxil hemihydrate)1978 · FDA new drug approval · Allergan plc headquarters, IrelandNew drug approved by the FDA on 1978-02-17. Active ingredient: cefadroxil/cefadroxil hemihydrate. Sponsor: Warner Chilcott. Application NDA050512.FDA Drugs@FDA, application NDA050512 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050512)
• Elspar (asparaginase)1978 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1978-01-10. Active ingredient: asparaginase. Sponsor: Merck. Application BLA101063.FDA Drugs@FDA, application BLA101063 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=101063)
• Glucoscan (technetium tc-99m gluceptate kit)1978 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1978-05-25. Active ingredient: technetium tc-99m gluceptate kit. Sponsor: Bristol Myers Squibb. Application NDA017907.FDA Drugs@FDA, application NDA017907 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017907)
• Mandol (cefamandole nafate)1978 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1978-09-27. Active ingredient: cefamandole nafate. Sponsor: Lilly. Application NDA050504.FDA Drugs@FDA, application NDA050504 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050504)
• Timoptic (timolol maleate)1978 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1978-08-17. Active ingredient: timolol maleate. Sponsor: Bausch And Lomb Inc. Application NDA018086.FDA Drugs@FDA, application NDA018086 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018086)
• Ceclor (cefaclor)1979 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1979-04-04. Active ingredient: cefaclor. Sponsor: Lilly. Application NDA050521.FDA Drugs@FDA, application NDA050521 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050521)
• Cyclocort (amcinonide)1979 · FDA new drug approval · Astellas Pharma headquarters, ChūōNew drug approved by the FDA on 1979-10-18. Active ingredient: amcinonide. Sponsor: Astellas. Application NDA018116.FDA Drugs@FDA, application NDA018116 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018116)
• Demser (metyrosine)1979 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1979-10-03. Active ingredient: metyrosine. Sponsor: Bausch. Application NDA017871.FDA Drugs@FDA, application NDA017871 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017871)
• Hemabate (carboprost tromethamine)1979 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1979-01-09. Active ingredient: carboprost tromethamine. Sponsor: Pfizer. Application NDA017989.FDA Drugs@FDA, application NDA017989 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017989)
• Liposyn 10% (safflower oil)1979 · FDA new drug approval · Abbott Laboratories headquarters, North ChicagoNew drug approved by the FDA on 1979-05-16. Active ingredient: safflower oil. Sponsor: Abbott. Application NDA018203.FDA Drugs@FDA, application NDA018203 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018203)
• Loniten (minoxidil)1979 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1979-10-18. Active ingredient: minoxidil. Sponsor: Pfizer. Application NDA018154.FDA Drugs@FDA, application NDA018154 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018154)
• Reglan (metoclopramide hydrochloride)1979 · FDA new drug approval · Hikma Pharmaceuticals headquarters, LondonNew drug approved by the FDA on 1979-02-07. Active ingredient: metoclopramide hydrochloride. Sponsor: Hikma. Application NDA017862.FDA Drugs@FDA, application NDA017862 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017862)
• Calderol (calcifediol)1980 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1980-08-05. Active ingredient: calcifediol. Sponsor: Organon Usa Inc. Application NDA018312.FDA Drugs@FDA, application NDA018312 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018312)
• Cinobac (cinoxacin)1980 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1980-06-13. Active ingredient: cinoxacin. Sponsor: Lilly. Application NDA018067.FDA Drugs@FDA, application NDA018067 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018067)
• Cytadren (aminoglutethimide)1980 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1980-10-29. Active ingredient: aminoglutethimide. Sponsor: Novartis. Application NDA018202.FDA Drugs@FDA, application NDA018202 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018202)
• Ludiomil (maprotiline hydrochloride)1980 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1980-12-01. Active ingredient: maprotiline hydrochloride. Sponsor: Novartis. Application NDA017543.FDA Drugs@FDA, application NDA017543 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017543)
• Spectrobid (bacampicillin hydrochloride)1980 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1980-12-22. Active ingredient: bacampicillin hydrochloride. Sponsor: Pfizer. Application NDA050520.FDA Drugs@FDA, application NDA050520 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050520)
• Vansil (oxamniquine)1980 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1980-07-23. Active ingredient: oxamniquine. Sponsor: Pfizer. Application NDA018069.FDA Drugs@FDA, application NDA018069 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018069)
• Buprenex (buprenorphine hydrochloride)1981 · FDA new drug approval · Indivior headquarters, RichmondNew drug approved by the FDA on 1981-12-29. Active ingredient: buprenorphine hydrochloride. Sponsor: Indivior. Application NDA018401.FDA Drugs@FDA, application NDA018401 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018401)
• Carafate (sucralfate)1981 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1981-10-30. Active ingredient: sucralfate. Sponsor: Abbvie. Application NDA018333.FDA Drugs@FDA, application NDA018333 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018333)
• Lymphazurin (isosulfan blue)1981 · FDA new drug approval · Covidien headquarters, DublinNew drug approved by the FDA on 1981-07-29. Active ingredient: isosulfan blue. Sponsor: Covidien. Application NDA018310.FDA Drugs@FDA, application NDA018310 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018310)
• Paxipam (halazepam)1981 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1981-09-24. Active ingredient: halazepam. Sponsor: Schering. Application NDA017736.FDA Drugs@FDA, application NDA017736 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017736)
• Procardia (nifedipine)1981 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1981-12-31. Active ingredient: nifedipine. Sponsor: Pfizer. Application NDA018482.FDA Drugs@FDA, application NDA018482 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018482)
• Prostin Vr Pediatric (alprostadil)1981 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1981-10-16. Active ingredient: alprostadil. Sponsor: Pfizer. Application NDA018484.FDA Drugs@FDA, application NDA018484 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018484)
• Proventil (albuterol)1981 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1981-05-01. Active ingredient: albuterol. Sponsor: Schering. Application NDA017559.FDA Drugs@FDA, application NDA017559 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017559)
• Xanax (alprazolam)1981 · FDA new drug approval · Upjohn headquarters, MichiganNew drug approved by the FDA on 1981-10-16. Active ingredient: alprazolam. Sponsor: Upjohn. Application NDA018276.FDA Drugs@FDA, application NDA018276 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018276)
• Accutane (isotretinoin)1982 · FDA new drug approval · Hoffmann-La Roche headquarters, BaselNew drug approved by the FDA on 1982-05-07. Active ingredient: isotretinoin. Sponsor: Hoffmann La Roche. Application NDA018662.FDA Drugs@FDA, application NDA018662 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018662)
• Amidate (etomidate)1982 · FDA new drug approval · Hospira headquarters, Lake ForestNew drug approved by the FDA on 1982-09-07. Active ingredient: etomidate. Sponsor: Hospira. Application NDA018227.FDA Drugs@FDA, application NDA018227 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018227)
• Cardizem (diltiazem hydrochloride)1982 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1982-11-05. Active ingredient: diltiazem hydrochloride. Sponsor: Bausch. Application NDA018602.FDA Drugs@FDA, application NDA018602 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018602)
• Cefobid (cefoperazone sodium)1982 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1982-11-18. Active ingredient: cefoperazone sodium. Sponsor: Pfizer. Application NDA050551.FDA Drugs@FDA, application NDA050551 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050551)
• Dolobid (diflunisal)1982 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1982-04-19. Active ingredient: diflunisal. Sponsor: Merck. Application NDA018445.FDA Drugs@FDA, application NDA018445 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018445)
• Factrel (gonadorelin hydrochloride)1982 · FDA new drug approval · Hikma Pharmaceuticals headquarters, LondonNew drug approved by the FDA on 1982-09-30. Active ingredient: gonadorelin hydrochloride. Sponsor: Hikma. Application NDA018123.FDA Drugs@FDA, application NDA018123 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018123)
• Feldene (piroxicam)1982 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1982-04-06. Active ingredient: piroxicam. Sponsor: Pfizer. Application NDA018147.FDA Drugs@FDA, application NDA018147 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018147)
• Halcion (triazolam)1982 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1982-11-15. Active ingredient: triazolam. Sponsor: Pfizer. Application NDA017892.FDA Drugs@FDA, application NDA017892 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017892)
• Humulin R Pen (insulin human, insulin recombinant human)1982 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1982-10-28. Active ingredient: insulin human, insulin recombinant human. Sponsor: Lilly. Application BLA018780.FDA Drugs@FDA, application BLA018780 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018780)
• Loprox (ciclopirox)1982 · FDA new drug approval · Eurofarma headquarters, São PauloNew drug approved by the FDA on 1982-12-30. Active ingredient: ciclopirox. Sponsor: Eurofarma. Application NDA018748.FDA Drugs@FDA, application NDA018748 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018748)
• Mpi Dmsa Kidney Reagent (technetium tc-99m succimer kit)1982 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1982-05-18. Active ingredient: technetium tc-99m succimer kit. Sponsor: Ge Healthcare. Application NDA017944.FDA Drugs@FDA, application NDA017944 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017944)
• Mpi Indium Dtpa In 111 (indium in-111 pentetate disodium)1982 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1982-02-18. Active ingredient: indium in-111 pentetate disodium. Sponsor: Ge Healthcare. Application NDA017707.FDA Drugs@FDA, application NDA017707 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017707)
• Visken (pindolol)1982 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1982-09-03. Active ingredient: pindolol. Sponsor: Novartis. Application NDA018285.FDA Drugs@FDA, application NDA018285 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018285)
• Xenon Xe 127 (xenon xe-127)1982 · FDA new drug approval · Mallinckrodt Pharmaceuticals headquarters, IrelandNew drug approved by the FDA on 1982-10-01. Active ingredient: xenon xe-127. Sponsor: Mallinckrodt. Application NDA018536.FDA Drugs@FDA, application NDA018536 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018536)
• Zovirax (acyclovir)1982 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1982-03-29. Active ingredient: acyclovir. Sponsor: Bausch. Application NDA018604.FDA Drugs@FDA, application NDA018604 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018604)
• Cefizox (ceftizoxime sodium)1983 · FDA new drug approval · Astellas Pharma headquarters, ChūōNew drug approved by the FDA on 1983-09-15. Active ingredient: ceftizoxime sodium. Sponsor: Astellas. Application NDA050560.FDA Drugs@FDA, application NDA050560 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050560)
• Lozol (indapamide)1983 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1983-07-06. Active ingredient: indapamide. Sponsor: Sanofi Aventis Us. Application NDA018538.FDA Drugs@FDA, application NDA018538 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018538)
• Netromycin (netilmicin sulfate)1983 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1983-02-28. Active ingredient: netilmicin sulfate. Sponsor: Schering. Application NDA050544.FDA Drugs@FDA, application NDA050544 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050544)
• Sandimmune (cyclosporine)1983 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1983-11-14. Active ingredient: cyclosporine. Sponsor: Novartis. Application NDA050573.FDA Drugs@FDA, application NDA050573 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050573)
• Tracrium Preservative Free (atracurium besylate)1983 · FDA new drug approval · Hospira headquarters, Lake ForestNew drug approved by the FDA on 1983-11-23. Active ingredient: atracurium besylate. Sponsor: Hospira. Application NDA018831.FDA Drugs@FDA, application NDA018831 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018831)
• Tz-3 (tioconazole)1983 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1983-02-18. Active ingredient: tioconazole. Sponsor: Pfizer. Application NDA018682.FDA Drugs@FDA, application NDA018682 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018682)
• Glucotrol (glipizide)1984 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1984-05-08. Active ingredient: glipizide. Sponsor: Pfizer. Application NDA017783.FDA Drugs@FDA, application NDA017783 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017783)
• Inocor (inamrinone lactate)1984 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1984-07-31. Active ingredient: inamrinone lactate. Sponsor: Sanofi Aventis Us. Application NDA018700.FDA Drugs@FDA, application NDA018700 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018700)
• Micronase (glyburide)1984 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1984-05-01. Active ingredient: glyburide. Sponsor: Pfizer. Application NDA017498.FDA Drugs@FDA, application NDA017498 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017498)
• Nephroflow (iodohippurate sodium i-123)1984 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1984-12-28. Active ingredient: iodohippurate sodium i-123. Sponsor: Ge Healthcare. Application NDA018289.FDA Drugs@FDA, application NDA018289 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018289)
• Nicorette (nicotine polacrilex)1984 · FDA new drug approval · Haleon headquarters, WeybridgeNew drug approved by the FDA on 1984-01-13. Active ingredient: nicotine polacrilex. Sponsor: Haleon Us Holdings. Application NDA018612.FDA Drugs@FDA, application NDA018612 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018612)
• Norcuron (vecuronium bromide)1984 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1984-04-30. Active ingredient: vecuronium bromide. Sponsor: Organon Usa Inc. Application NDA018776.FDA Drugs@FDA, application NDA018776 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018776)
• Normodyne (labetalol hydrochloride)1984 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1984-08-01. Active ingredient: labetalol hydrochloride. Sponsor: Schering. Application NDA018686.FDA Drugs@FDA, application NDA018686 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018686)
• Pentam (pentamidine isethionate)1984 · FDA new drug approval · Fresenius Kabi headquarters, Bad Homburg vor der HöheNew drug approved by the FDA on 1984-10-16. Active ingredient: pentamidine isethionate. Sponsor: Fresenius Kabi Usa. Application NDA019264.FDA Drugs@FDA, application NDA019264 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019264)
• Rocephin Kit (ceftriaxone sodium, lidocaine)1984 · FDA new drug approval · Hoffmann-La Roche headquarters, BaselNew drug approved by the FDA on 1984-12-21. Active ingredient: ceftriaxone sodium, lidocaine. Sponsor: Hoffmann La Roche. Application NDA050585.FDA Drugs@FDA, application NDA050585 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050585)
• Tonocard (tocainide hydrochloride)1984 · FDA new drug approval · AstraZeneca headquarters, CambridgeNew drug approved by the FDA on 1984-11-09. Active ingredient: tocainide hydrochloride. Sponsor: Astrazeneca. Application NDA018257.FDA Drugs@FDA, application NDA018257 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018257)
• Tornalate (bitolterol mesylate)1984 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1984-12-28. Active ingredient: bitolterol mesylate. Sponsor: Sanofi Aventis Us. Application NDA018770.FDA Drugs@FDA, application NDA018770 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018770)
• Baros (sodium bicarbonate, tartaric acid)1985 · FDA new drug approval · Mallinckrodt Pharmaceuticals headquarters, IrelandNew drug approved by the FDA on 1985-08-07. Active ingredient: sodium bicarbonate, tartaric acid. Sponsor: Mallinckrodt Inc. Application NDA018509.FDA Drugs@FDA, application NDA018509 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018509)
• Betagan (levobunolol hydrochloride)1985 · FDA new drug approval · Allergan plc headquarters, IrelandNew drug approved by the FDA on 1985-12-19. Active ingredient: levobunolol hydrochloride. Sponsor: Allergan. Application NDA019219.FDA Drugs@FDA, application NDA019219 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019219)
• Betoptic (betaxolol hydrochloride)1985 · FDA new drug approval · Sandoz headquarters, BaselNew drug approved by the FDA on 1985-08-30. Active ingredient: betaxolol hydrochloride. Sponsor: Sandoz. Application NDA019270.FDA Drugs@FDA, application NDA019270 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019270)
• Cesamet (nabilone)1985 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1985-12-26. Active ingredient: nabilone. Sponsor: Bausch. Application NDA018677.FDA Drugs@FDA, application NDA018677 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018677)
• Indium In 111 Oxyquinoline (indium in-111 oxyquinoline)1985 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1985-12-24. Active ingredient: indium in-111 oxyquinoline. Sponsor: Ge Healthcare. Application NDA019044.FDA Drugs@FDA, application NDA019044 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019044)
• Mexitil (mexiletine hydrochloride)1985 · FDA new drug approval · Boehringer Ingelheim headquarters, Ingelheim am RheinNew drug approved by the FDA on 1985-12-30. Active ingredient: mexiletine hydrochloride. Sponsor: Boehringer Ingelheim. Application NDA018873.FDA Drugs@FDA, application NDA018873 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018873)
• Omnipaque 140 (iohexol)1985 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1985-12-26. Active ingredient: iohexol. Sponsor: Ge Healthcare. Application NDA018956.FDA Drugs@FDA, application NDA018956 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018956)
• Syprine (trientine hydrochloride)1985 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1985-11-08. Active ingredient: trientine hydrochloride. Sponsor: Bausch. Application NDA019194.FDA Drugs@FDA, application NDA019194 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019194)
• Vasotec (enalapril maleate)1985 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1985-12-24. Active ingredient: enalapril maleate. Sponsor: Bausch. Application NDA018998.FDA Drugs@FDA, application NDA018998 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018998)
• Virazole (ribavirin)1985 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1985-12-31. Active ingredient: ribavirin. Sponsor: Bausch. Application NDA018859.FDA Drugs@FDA, application NDA018859 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018859)
• Wellbutrin (bupropion hydrochloride)1985 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1985-12-30. Active ingredient: bupropion hydrochloride. Sponsor: Glaxosmithkline. Application NDA018644.FDA Drugs@FDA, application NDA018644 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018644)
• Atrovent (ipratropium bromide)1986 · FDA new drug approval · Boehringer Ingelheim headquarters, Ingelheim am RheinNew drug approved by the FDA on 1986-12-29. Active ingredient: ipratropium bromide. Sponsor: Boehringer Ingelheim. Application NDA019085.FDA Drugs@FDA, application NDA019085 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019085)
• Buspar (buspirone hydrochloride)1986 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1986-09-29. Active ingredient: buspirone hydrochloride. Sponsor: Bristol Myers Squibb. Application NDA018731.FDA Drugs@FDA, application NDA018731 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018731)
• Cibacalcin (calcitonin human)1986 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1986-10-31. Active ingredient: calcitonin human. Sponsor: Novartis. Application NDA018470.FDA Drugs@FDA, application NDA018470 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018470)
• Intron A (interferon alfa-2b)1986 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1986-06-04. Active ingredient: interferon alfa-2b. Sponsor: Schering. Application BLA103132.FDA Drugs@FDA, application BLA103132 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103132)
• Lamprene (clofazimine)1986 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1986-12-15. Active ingredient: clofazimine. Sponsor: Novartis. Application NDA019500.FDA Drugs@FDA, application NDA019500 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019500)
• Maxair (pirbuterol acetate)1986 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1986-12-30. Active ingredient: pirbuterol acetate. Sponsor: Bausch. Application NDA019009.FDA Drugs@FDA, application NDA019009 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019009)
• Nix (permethrin)1986 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1986-03-31. Active ingredient: permethrin. Sponsor: Glaxosmithkline. Application NDA019435.FDA Drugs@FDA, application NDA019435 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019435)
• Noroxin (norfloxacin)1986 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1986-10-31. Active ingredient: norfloxacin. Sponsor: Merck. Application NDA019384.FDA Drugs@FDA, application NDA019384 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019384)
• Ocufen (flurbiprofen sodium)1986 · FDA new drug approval · Allergan plc headquarters, IrelandNew drug approved by the FDA on 1986-12-31. Active ingredient: flurbiprofen sodium. Sponsor: Allergan. Application NDA019404.FDA Drugs@FDA, application NDA019404 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019404)
• Pepcid (famotidine)1986 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1986-10-15. Active ingredient: famotidine. Sponsor: Bausch. Application NDA019462.FDA Drugs@FDA, application NDA019462 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019462)
• Actigall (ursodiol)1987 · FDA new drug approval · Teva Pharmaceutical Industries Ltd. headquarters, Ramat HaHayalNew drug approved by the FDA on 1987-12-31. Active ingredient: ursodiol. Sponsor: Teva Branded Pharm. Application NDA019594.FDA Drugs@FDA, application NDA019594 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019594)
• Activase (alteplase)1987 · FDA new drug approval · Genentech headquarters, South San FranciscoNew drug approved by the FDA on 1987-11-13. Active ingredient: alteplase. Sponsor: Genentech. Application BLA103172.FDA Drugs@FDA, application BLA103172 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103172)
• Bactroban (mupirocin)1987 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1987-12-31. Active ingredient: mupirocin. Sponsor: Glaxosmithkline. Application NDA050591.FDA Drugs@FDA, application NDA050591 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050591)
• Elocon (mometasone furoate)1987 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1987-04-30. Active ingredient: mometasone furoate. Sponsor: Organon. Application NDA019543.FDA Drugs@FDA, application NDA019543 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019543)
• Hytrin (terazosin hydrochloride)1987 · FDA new drug approval · Abbott Laboratories headquarters, North ChicagoNew drug approved by the FDA on 1987-08-07. Active ingredient: terazosin hydrochloride. Sponsor: Abbott. Application NDA019057.FDA Drugs@FDA, application NDA019057 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019057)
• Mevacor (lovastatin)1987 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1987-08-31. Active ingredient: lovastatin. Sponsor: Merck. Application NDA019643.FDA Drugs@FDA, application NDA019643 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019643)
• Novantrone (mitoxantrone hydrochloride)1987 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1987-12-23. Active ingredient: mitoxantrone hydrochloride. Sponsor: Emd Serono. Application NDA019297.FDA Drugs@FDA, application NDA019297 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019297)
• Primacor (milrinone lactate)1987 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1987-12-31. Active ingredient: milrinone lactate. Sponsor: Sanofi Aventis Us. Application NDA019436.FDA Drugs@FDA, application NDA019436 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019436)
• Prinivil (lisinopril)1987 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1987-12-29. Active ingredient: lisinopril. Sponsor: Merck. Application NDA019558.FDA Drugs@FDA, application NDA019558 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019558)
• Sarafem (fluoxetine hydrochloride)1987 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1987-12-29. Active ingredient: fluoxetine hydrochloride. Sponsor: Eli Lilly And Co. Application NDA018936.FDA Drugs@FDA, application NDA018936 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018936)
• Axid (nizatidine)1988 · FDA new drug approval · SmithKline Beecham headquarters, West ChesterNew drug approved by the FDA on 1988-04-12. Active ingredient: nizatidine. Sponsor: Smithkline Beecham. Application NDA019508.FDA Drugs@FDA, application NDA019508 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019508)
• Cardene (nicardipine hydrochloride)1988 · FDA new drug approval · Chiesi Farmaceutici S.p.A. headquarters, ParmaNew drug approved by the FDA on 1988-12-21. Active ingredient: nicardipine hydrochloride. Sponsor: Chiesi. Application NDA019488.FDA Drugs@FDA, application NDA019488 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019488)
• Cartrol (carteolol hydrochloride)1988 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1988-12-28. Active ingredient: carteolol hydrochloride. Sponsor: Abbvie. Application NDA019204.FDA Drugs@FDA, application NDA019204 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019204)
• Ceradon (cefotiam hydrochloride)1988 · FDA new drug approval · Takeda Pharmaceutical Company headquarters, OsakaNew drug approved by the FDA on 1988-12-30. Active ingredient: cefotiam hydrochloride. Sponsor: Takeda. Application NDA050601.FDA Drugs@FDA, application NDA050601 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050601)
• Ceretec (technetium tc-99m exametazime kit)1988 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1988-12-30. Active ingredient: technetium tc-99m exametazime kit. Sponsor: Ge Healthcare. Application NDA019829.FDA Drugs@FDA, application NDA019829 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019829)
• Cytotec (misoprostol)1988 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1988-12-27. Active ingredient: misoprostol. Sponsor: Pfizer. Application NDA019268.FDA Drugs@FDA, application NDA019268 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019268)
• Sandostatin (octreotide acetate)1988 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1988-10-21. Active ingredient: octreotide acetate. Sponsor: Novartis. Application NDA019667.FDA Drugs@FDA, application NDA019667 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019667)
• Voltaren (diclofenac sodium)1988 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1988-07-28. Active ingredient: diclofenac sodium. Sponsor: Novartis. Application NDA019201.FDA Drugs@FDA, application NDA019201 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019201)
• Adenocard (adenosine)1989 · FDA new drug approval · Astellas Pharma headquarters, ChūōNew drug approved by the FDA on 1989-10-30. Active ingredient: adenosine. Sponsor: Astellas. Application NDA019937.FDA Drugs@FDA, application NDA019937 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019937)
• Cytovene (ganciclovir sodium)1989 · FDA new drug approval · Cheplapharm Arzneimittel headquarters, GreifswaldNew drug approved by the FDA on 1989-06-23. Active ingredient: ganciclovir sodium. Sponsor: Cheplapharm. Application NDA019661.FDA Drugs@FDA, application NDA019661 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019661)
• Decabid (indecainide hydrochloride)1989 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1989-12-29. Active ingredient: indecainide hydrochloride. Sponsor: Lilly. Application NDA019693.FDA Drugs@FDA, application NDA019693 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019693)
• Diprivan (propofol)1989 · FDA new drug approval · Fresenius Kabi headquarters, Bad Homburg vor der HöheNew drug approved by the FDA on 1989-10-02. Active ingredient: propofol. Sponsor: Fresenius Kabi Usa. Application NDA019627.FDA Drugs@FDA, application NDA019627 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019627)
• Epogen/Procrit (epoetin alfa)1989 · FDA new drug approval · Amgen headquarters, Thousand OaksNew drug approved by the FDA on 1989-06-01. Active ingredient: epoetin alfa. Sponsor: Amgen. Application BLA103234.FDA Drugs@FDA, application BLA103234 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103234)
• Eulexin (flutamide)1989 · FDA new drug approval · Schering AG headquarters, BerlinNew drug approved by the FDA on 1989-01-27. Active ingredient: flutamide. Sponsor: Schering. Application NDA018554.FDA Drugs@FDA, application NDA018554 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018554)
• Optipranolol (metipranolol hydrochloride)1989 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1989-12-29. Active ingredient: metipranolol hydrochloride. Sponsor: Bausch And Lomb. Application NDA019907.FDA Drugs@FDA, application NDA019907 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019907)
• Pindac (pinacidil)1989 · FDA new drug approval · LEO Pharma headquarters, BallerupNew drug approved by the FDA on 1989-12-28. Active ingredient: pinacidil. Sponsor: Leo Pharm. Application NDA019456.FDA Drugs@FDA, application NDA019456 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019456)
• Prilosec (omeprazole)1989 · FDA new drug approval · AstraZeneca headquarters, CambridgeNew drug approved by the FDA on 1989-09-14. Active ingredient: omeprazole. Sponsor: Astrazeneca. Application NDA019810.FDA Drugs@FDA, application NDA019810 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019810)
• Rythmol (propafenone hydrochloride)1989 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1989-11-27. Active ingredient: propafenone hydrochloride. Sponsor: Glaxosmithkline Llc. Application NDA019151.FDA Drugs@FDA, application NDA019151 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019151)
• Arduan (pipecuronium bromide)1990 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1990-06-26. Active ingredient: pipecuronium bromide. Sponsor: Organon Usa Inc. Application NDA019638.FDA Drugs@FDA, application NDA019638 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019638)
• Cardura (doxazosin mesylate)1990 · FDA new drug approval · Viatris headquarters, PittsburghNew drug approved by the FDA on 1990-11-02. Active ingredient: doxazosin mesylate. Sponsor: Viatris. Application NDA019668.FDA Drugs@FDA, application NDA019668 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019668)
• Diflucan (fluconazole)1990 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1990-01-29. Active ingredient: fluconazole. Sponsor: Pfizer. Application NDA019949.FDA Drugs@FDA, application NDA019949 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019949)
• Dynacirc (isradipine)1990 · FDA new drug approval · SmithKline Beecham headquarters, West ChesterNew drug approved by the FDA on 1990-12-20. Active ingredient: isradipine. Sponsor: Smithkline Beecham. Application NDA019546.FDA Drugs@FDA, application NDA019546 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019546)
• Ethmozine (moricizine hydrochloride)1990 · FDA new drug approval · Shire plc headquarters, BasingstokeNew drug approved by the FDA on 1990-06-19. Active ingredient: moricizine hydrochloride. Sponsor: Shire. Application NDA019753.FDA Drugs@FDA, application NDA019753 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019753)
• Geref (sermorelin acetate)1990 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1990-12-28. Active ingredient: sermorelin acetate. Sponsor: Emd Serono. Application NDA019863.FDA Drugs@FDA, application NDA019863 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019863)
• Hexalen (altretamine)1990 · FDA new drug approval · Eisai headquarters, TokyoNew drug approved by the FDA on 1990-12-26. Active ingredient: altretamine. Sponsor: Eisai Inc. Application NDA019926.FDA Drugs@FDA, application NDA019926 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019926)
• Idamycin (idarubicin hydrochloride)1990 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1990-09-27. Active ingredient: idarubicin hydrochloride. Sponsor: Pfizer. Application NDA050661.FDA Drugs@FDA, application NDA050661 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050661)
• Ornidyl (eflornithine hydrochloride)1990 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1990-11-28. Active ingredient: eflornithine hydrochloride. Sponsor: Sanofi Aventis Us. Application NDA019879.FDA Drugs@FDA, application NDA019879 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019879)
• Prosom (estazolam)1990 · FDA new drug approval · Abbott Laboratories headquarters, North ChicagoNew drug approved by the FDA on 1990-12-26. Active ingredient: estazolam. Sponsor: Abbott. Application NDA019080.FDA Drugs@FDA, application NDA019080 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019080)
• Synarel (nafarelin acetate)1990 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1990-02-13. Active ingredient: nafarelin acetate. Sponsor: Pfizer. Application NDA019886.FDA Drugs@FDA, application NDA019886 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019886)
• Vascor (bepridil hydrochloride)1990 · FDA new drug approval · Johnson & Johnson headquarters, New BrunswickNew drug approved by the FDA on 1990-12-28. Active ingredient: bepridil hydrochloride. Sponsor: Johnson And Johnson. Application NDA019002.FDA Drugs@FDA, application NDA019002 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019002)
• Aredia (pamidronate disodium)1991 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1991-10-31. Active ingredient: pamidronate disodium. Sponsor: Novartis. Application NDA020036.FDA Drugs@FDA, application NDA020036 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020036)
• Biaxin (clarithromycin)1991 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1991-10-31. Active ingredient: clarithromycin. Sponsor: Abbvie. Application NDA050662.FDA Drugs@FDA, application NDA050662 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050662)
• Botox Cosmetic (onabotulinumtoxina)1991 · FDA new drug approval · Allergan plc headquarters, IrelandNew drug approved by the FDA on 1991-12-09. Active ingredient: onabotulinumtoxina. Sponsor: Allergan. Application BLA103000.FDA Drugs@FDA, application BLA103000 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103000)
• Fludara (fludarabine phosphate)1991 · FDA new drug approval · Genzyme headquarters, CambridgeNew drug approved by the FDA on 1991-04-18. Active ingredient: fludarabine phosphate. Sponsor: Genzyme Corp. Application NDA020038.FDA Drugs@FDA, application NDA020038 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020038)
• Monopril (fosinopril sodium)1991 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1991-05-16. Active ingredient: fosinopril sodium. Sponsor: Bristol Myers Squibb. Application NDA019915.FDA Drugs@FDA, application NDA019915 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019915)
• Neupogen (filgrastim)1991 · FDA new drug approval · Amgen headquarters, Thousand OaksNew drug approved by the FDA on 1991-02-20. Active ingredient: filgrastim. Sponsor: Amgen. Application BLA103353.FDA Drugs@FDA, application BLA103353 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103353)
• Nipent (pentostatin)1991 · FDA new drug approval · Hospira headquarters, Lake ForestNew drug approved by the FDA on 1991-10-11. Active ingredient: pentostatin. Sponsor: Hospira Inc. Application NDA020122.FDA Drugs@FDA, application NDA020122 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020122)
• Nuromax (doxacurium chloride)1991 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1991-03-07. Active ingredient: doxacurium chloride. Sponsor: Abbvie. Application NDA019946.FDA Drugs@FDA, application NDA019946 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019946)
• Penetrex (enoxacin)1991 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1991-12-31. Active ingredient: enoxacin. Sponsor: Sanofi Aventis Us. Application NDA019616.FDA Drugs@FDA, application NDA019616 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019616)
• Plendil (felodipine)1991 · FDA new drug approval · AstraZeneca headquarters, CambridgeNew drug approved by the FDA on 1991-07-25. Active ingredient: felodipine. Sponsor: Astrazeneca. Application NDA019834.FDA Drugs@FDA, application NDA019834 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019834)
• Pravachol (pravastatin sodium)1991 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1991-10-31. Active ingredient: pravastatin sodium. Sponsor: Bristol Myers Squibb. Application NDA019898.FDA Drugs@FDA, application NDA019898 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019898)
• Relafen (nabumetone)1991 · FDA new drug approval · SmithKline Beecham headquarters, West ChesterNew drug approved by the FDA on 1991-12-24. Active ingredient: nabumetone. Sponsor: Smithkline Beecham. Application NDA019583.FDA Drugs@FDA, application NDA019583 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019583)
• Romazicon (flumazenil)1991 · FDA new drug approval · Hoffmann-La Roche headquarters, BaselNew drug approved by the FDA on 1991-12-20. Active ingredient: flumazenil. Sponsor: Hoffmann La Roche. Application NDA020073.FDA Drugs@FDA, application NDA020073 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020073)
• Supprelin (histrelin acetate)1991 · FDA new drug approval · Shire plc headquarters, BasingstokeNew drug approved by the FDA on 1991-12-24. Active ingredient: histrelin acetate. Sponsor: Shire. Application NDA019836.FDA Drugs@FDA, application NDA019836 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019836)
• Survanta (beractant)1991 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1991-07-01. Active ingredient: beractant. Sponsor: Abbvie. Application BLA020032.FDA Drugs@FDA, application BLA020032 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020032)
• Videx (didanosine)1991 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1991-10-09. Active ingredient: didanosine. Sponsor: Bristol Myers Squibb. Application NDA020154.FDA Drugs@FDA, application NDA020154 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020154)
• Zithromax (azithromycin)1991 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1991-11-01. Active ingredient: azithromycin. Sponsor: Pfizer. Application NDA050670.FDA Drugs@FDA, application NDA050670 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050670)
• Zocor (simvastatin)1991 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1991-12-23. Active ingredient: simvastatin. Sponsor: Organon. Application NDA019766.FDA Drugs@FDA, application NDA019766 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019766)
• Zofran (ondansetron hydrochloride)1991 · FDA new drug approval · Sandoz headquarters, BaselNew drug approved by the FDA on 1991-01-04. Active ingredient: ondansetron hydrochloride. Sponsor: Sandoz. Application NDA020007.FDA Drugs@FDA, application NDA020007 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020007)
• Zoloft (sertraline hydrochloride)1991 · FDA new drug approval · Viatris headquarters, PittsburghNew drug approved by the FDA on 1991-12-30. Active ingredient: sertraline hydrochloride. Sponsor: Viatris. Application NDA019839.FDA Drugs@FDA, application NDA019839 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019839)
• Daypro (oxaprozin)1992 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1992-10-29. Active ingredient: oxaprozin. Sponsor: Pfizer. Application NDA018841.FDA Drugs@FDA, application NDA018841 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018841)
• Halfan (halofantrine hydrochloride)1992 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1992-07-24. Active ingredient: halofantrine hydrochloride. Sponsor: Glaxosmithkline. Application NDA020250.FDA Drugs@FDA, application NDA020250 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020250)
• Imitrex Statdose (Autoinjector) (sumatriptan succinate)1992 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1992-12-28. Active ingredient: sumatriptan succinate. Sponsor: Glaxosmithkline. Application NDA020080.FDA Drugs@FDA, application NDA020080 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020080)
• Indiclor (indium in-111 chloride)1992 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1992-12-29. Active ingredient: indium in-111 chloride. Sponsor: Ge Healthcare. Application NDA019862.FDA Drugs@FDA, application NDA019862 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019862)
• Lamisil (terbinafine hydrochloride)1992 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1992-12-30. Active ingredient: terbinafine hydrochloride. Sponsor: Novartis. Application NDA020192.FDA Drugs@FDA, application NDA020192 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020192)
• Maxaquin (lomefloxacin hydrochloride)1992 · FDA new drug approval · Pharmacia headquarters, UppsalaNew drug approved by the FDA on 1992-02-21. Active ingredient: lomefloxacin hydrochloride. Sponsor: Pharmacia. Application NDA020013.FDA Drugs@FDA, application NDA020013 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020013)
• Mepron (atovaquone)1992 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1992-11-25. Active ingredient: atovaquone. Sponsor: Glaxosmithkline Llc. Application NDA020259.FDA Drugs@FDA, application NDA020259 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020259)
• Mivacron (mivacurium chloride)1992 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1992-01-22. Active ingredient: mivacurium chloride. Sponsor: Abbvie. Application NDA020098.FDA Drugs@FDA, application NDA020098 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020098)
• Mycobutin (rifabutin)1992 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1992-12-23. Active ingredient: rifabutin. Sponsor: Pfizer. Application NDA050689.FDA Drugs@FDA, application NDA050689 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050689)
• Norvasc (amlodipine besylate)1992 · FDA new drug approval · Viatris headquarters, PittsburghNew drug approved by the FDA on 1992-07-31. Active ingredient: amlodipine besylate. Sponsor: Viatris. Application NDA019787.FDA Drugs@FDA, application NDA019787 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019787)
• Paxil (paroxetine hydrochloride)1992 · FDA new drug approval · Apotex headquarters, TorontoNew drug approved by the FDA on 1992-12-29. Active ingredient: paroxetine hydrochloride. Sponsor: Apotex. Application NDA020031.FDA Drugs@FDA, application NDA020031 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020031)
• Proscar (finasteride)1992 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1992-06-19. Active ingredient: finasteride. Sponsor: Organon. Application NDA020180.FDA Drugs@FDA, application NDA020180 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020180)
• Vantin (cefpodoxime proxetil)1992 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1992-08-07. Active ingredient: cefpodoxime proxetil. Sponsor: Pfizer. Application NDA050674.FDA Drugs@FDA, application NDA050674 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050674)
• Zebeta (bisoprolol fumarate)1992 · FDA new drug approval · Teva Pharmaceutical Industries Ltd. headquarters, Ramat HaHayalNew drug approved by the FDA on 1992-07-31. Active ingredient: bisoprolol fumarate. Sponsor: Teva Branded Pharm. Application NDA019982.FDA Drugs@FDA, application NDA019982 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019982)
• Alomide (lodoxamide tromethamine)1993 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1993-09-23. Active ingredient: lodoxamide tromethamine. Sponsor: Novartis. Application NDA020191.FDA Drugs@FDA, application NDA020191 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020191)
• Claritin (loratadine)1993 · FDA new drug approval · Bayer HealthCare headquarters, LeverkusenNew drug approved by the FDA on 1993-04-12. Active ingredient: loratadine. Sponsor: Bayer Healthcare Llc. Application NDA019658.FDA Drugs@FDA, application NDA019658 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019658)
• Cognex (tacrine hydrochloride)1993 · FDA new drug approval · Shionogi headquarters, Chūō-kuNew drug approved by the FDA on 1993-09-09. Active ingredient: tacrine hydrochloride. Sponsor: Shionogi Inc. Application NDA020070.FDA Drugs@FDA, application NDA020070 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020070)
• Imagent (perflubron)1993 · FDA new drug approval · Alliance Pharmaceutical (United States) headquarters, San DiegoNew drug approved by the FDA on 1993-08-13. Active ingredient: perflubron. Sponsor: Alliance Pharm. Application NDA020091.FDA Drugs@FDA, application NDA020091 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020091)
• Lescol (fluvastatin sodium)1993 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1993-12-31. Active ingredient: fluvastatin sodium. Sponsor: Novartis. Application NDA020261.FDA Drugs@FDA, application NDA020261 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020261)
• Livostin (levocabastine hydrochloride)1993 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1993-11-10. Active ingredient: levocabastine hydrochloride. Sponsor: Novartis. Application NDA020219.FDA Drugs@FDA, application NDA020219 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020219)
• Lovenox (Preservative Free) (enoxaparin sodium)1993 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1993-03-29. Active ingredient: enoxaparin sodium. Sponsor: Sanofi Aventis Us. Application NDA020164.FDA Drugs@FDA, application NDA020164 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020164)
• Neurontin (gabapentin)1993 · FDA new drug approval · Viatris headquarters, PittsburghNew drug approved by the FDA on 1993-12-30. Active ingredient: gabapentin. Sponsor: Viatris. Application NDA020235.FDA Drugs@FDA, application NDA020235 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020235)
• Omniscan (gadodiamide)1993 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1993-01-08. Active ingredient: gadodiamide. Sponsor: Ge Healthcare. Application NDA020123.FDA Drugs@FDA, application NDA020123 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020123)
• Pulmozyme (dornase alfa)1993 · FDA new drug approval · Genentech headquarters, South San FranciscoNew drug approved by the FDA on 1993-12-30. Active ingredient: dornase alfa. Sponsor: Genentech. Application BLA103532.FDA Drugs@FDA, application BLA103532 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103532)
• Tricor (Micronized) (fenofibrate)1993 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1993-12-31. Active ingredient: fenofibrate. Sponsor: Abbvie. Application NDA019304.FDA Drugs@FDA, application NDA019304 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019304)
• Cerezyme (imiglucerase)1994 · FDA new drug approval · Genzyme headquarters, CambridgeNew drug approved by the FDA on 1994-05-23. Active ingredient: imiglucerase. Sponsor: Genzyme. Application BLA020367.FDA Drugs@FDA, application BLA020367 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020367)
• Cystagon (cysteamine bitartrate)1994 · FDA new drug approval · Mylan headquarters, CanonsburgNew drug approved by the FDA on 1994-08-15. Active ingredient: cysteamine bitartrate. Sponsor: Mylan. Application NDA020392.FDA Drugs@FDA, application NDA020392 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020392)
• Famvir (famciclovir)1994 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1994-06-29. Active ingredient: famciclovir. Sponsor: Novartis. Application NDA020363.FDA Drugs@FDA, application NDA020363 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020363)
• Fragmin (dalteparin sodium)1994 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1994-12-22. Active ingredient: dalteparin sodium. Sponsor: Pfizer. Application NDA020287.FDA Drugs@FDA, application NDA020287 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020287)
• Lamictal (lamotrigine)1994 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1994-12-27. Active ingredient: lamotrigine. Sponsor: Glaxosmithkline Llc. Application NDA020241.FDA Drugs@FDA, application NDA020241 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020241)
• Luvox (fluvoxamine maleate)1994 · FDA new drug approval · Solvay S.A. headquarters, BrusselsNew drug approved by the FDA on 1994-12-05. Active ingredient: fluvoxamine maleate. Sponsor: Solvay. Application NDA020243.FDA Drugs@FDA, application NDA020243 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020243)
• Prograf (tacrolimus)1994 · FDA new drug approval · Astellas Pharma headquarters, ChūōNew drug approved by the FDA on 1994-04-08. Active ingredient: tacrolimus. Sponsor: Astellas. Application NDA050708.FDA Drugs@FDA, application NDA050708 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050708)
• Reopro (abciximab)1994 · FDA new drug approval · Janssen Biotech headquarters, HorshamNew drug approved by the FDA on 1994-12-22. Active ingredient: abciximab. Sponsor: Centocor Inc. Application BLA103575.FDA Drugs@FDA, application BLA103575 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103575)
• Rhinocort (budesonide)1994 · FDA new drug approval · AstraZeneca headquarters, CambridgeNew drug approved by the FDA on 1994-02-14. Active ingredient: budesonide. Sponsor: Astrazeneca. Application NDA020233.FDA Drugs@FDA, application NDA020233 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020233)
• Serevent (salmeterol xinafoate)1994 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1994-02-04. Active ingredient: salmeterol xinafoate. Sponsor: Glaxosmithkline. Application NDA020236.FDA Drugs@FDA, application NDA020236 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020236)
• Serzone (nefazodone hydrochloride)1994 · FDA new drug approval · Bristol-Myers Squibb headquarters, New York CityNew drug approved by the FDA on 1994-12-22. Active ingredient: nefazodone hydrochloride. Sponsor: Bristol Myers Squibb. Application NDA020152.FDA Drugs@FDA, application NDA020152 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020152)
• Zemuron (rocuronium bromide)1994 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1994-03-17. Active ingredient: rocuronium bromide. Sponsor: Organon Usa Inc. Application NDA020214.FDA Drugs@FDA, application NDA020214 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020214)
• Amaryl (glimepiride)1995 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1995-11-30. Active ingredient: glimepiride. Sponsor: Sanofi Aventis Us. Application NDA020496.FDA Drugs@FDA, application NDA020496 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020496)
• Azelex (azelaic acid)1995 · FDA new drug approval · Almirall headquarters, BarcelonaNew drug approved by the FDA on 1995-09-13. Active ingredient: azelaic acid. Sponsor: Almirall. Application NDA020428.FDA Drugs@FDA, application NDA020428 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020428)
• Corvert (ibutilide fumarate)1995 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1995-12-28. Active ingredient: ibutilide fumarate. Sponsor: Pfizer. Application NDA020491.FDA Drugs@FDA, application NDA020491 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020491)
• Cozaar (losartan potassium)1995 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1995-04-14. Active ingredient: losartan potassium. Sponsor: Organon. Application NDA020386.FDA Drugs@FDA, application NDA020386 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020386)
• Flolan (epoprostenol sodium)1995 · FDA new drug approval · GSK headquarters, LondonNew drug approved by the FDA on 1995-09-20. Active ingredient: epoprostenol sodium. Sponsor: Glaxosmithkline Llc. Application NDA020444.FDA Drugs@FDA, application NDA020444 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020444)
• Fosamax (alendronate sodium)1995 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1995-09-29. Active ingredient: alendronate sodium. Sponsor: Organon. Application NDA020560.FDA Drugs@FDA, application NDA020560 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020560)
• Glucophage (metformin hydrochloride)1995 · FDA new drug approval · Merck KGaA headquarters, DarmstadtNew drug approved by the FDA on 1995-03-03. Active ingredient: metformin hydrochloride. Sponsor: Emd Serono Inc. Application NDA020357.FDA Drugs@FDA, application NDA020357 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020357)
• Invirase (saquinavir mesylate)1995 · FDA new drug approval · Hoffmann-La Roche headquarters, BaselNew drug approved by the FDA on 1995-12-06. Active ingredient: saquinavir mesylate. Sponsor: Hoffmann La Roche. Application NDA020628.FDA Drugs@FDA, application NDA020628 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020628)
• Oxilan-350 (ioxilan)1995 · FDA new drug approval · Guerbet headquarters, VillepinteNew drug approved by the FDA on 1995-12-21. Active ingredient: ioxilan. Sponsor: Guerbet. Application NDA020316.FDA Drugs@FDA, application NDA020316 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020316)
• Revex (nalmefene hydrochloride)1995 · FDA new drug approval · Hikma Pharmaceuticals headquarters, LondonNew drug approved by the FDA on 1995-04-17. Active ingredient: nalmefene hydrochloride. Sponsor: Hikma. Application NDA020459.FDA Drugs@FDA, application NDA020459 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020459)
• Ultane (sevoflurane)1995 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1995-06-07. Active ingredient: sevoflurane. Sponsor: Abbvie. Application NDA020478.FDA Drugs@FDA, application NDA020478 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020478)
• Univasc (moexipril hydrochloride)1995 · FDA new drug approval · UCB headquarters, Brussels metropolitan areaNew drug approved by the FDA on 1995-04-19. Active ingredient: moexipril hydrochloride. Sponsor: Ucb Inc. Application NDA020312.FDA Drugs@FDA, application NDA020312 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020312)
• Zinecard (dexrazoxane hydrochloride)1995 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1995-05-26. Active ingredient: dexrazoxane hydrochloride. Sponsor: Pfizer. Application NDA020212.FDA Drugs@FDA, application NDA020212 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020212)
• Albenza (albendazole)1996 · FDA new drug approval · Amneal Pharmaceuticals, Inc. headquarters, HaywardNew drug approved by the FDA on 1996-06-11. Active ingredient: albendazole. Sponsor: Impax Labs Inc. Application NDA020666.FDA Drugs@FDA, application NDA020666 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020666)
• Alphagan (brimonidine tartrate)1996 · FDA new drug approval · Allergan plc headquarters, IrelandNew drug approved by the FDA on 1996-09-06. Active ingredient: brimonidine tartrate. Sponsor: Allergan. Application NDA020613.FDA Drugs@FDA, application NDA020613 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020613)
• Aricept (donepezil hydrochloride)1996 · FDA new drug approval · Eisai headquarters, TokyoNew drug approved by the FDA on 1996-11-25. Active ingredient: donepezil hydrochloride. Sponsor: Eisai Inc. Application NDA020690.FDA Drugs@FDA, application NDA020690 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020690)
• Avonex (interferon beta-1a)1996 · FDA new drug approval · Biogen headquarters, CambridgeNew drug approved by the FDA on 1996-05-17. Active ingredient: interferon beta-1a. Sponsor: Biogen. Application BLA103628.FDA Drugs@FDA, application BLA103628 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103628)
• Buphenyl (sodium phenylbutyrate)1996 · FDA new drug approval · Horizon Therapeutics headquarters, IrelandNew drug approved by the FDA on 1996-04-30. Active ingredient: sodium phenylbutyrate. Sponsor: Horizon Therap Us. Application NDA020573.FDA Drugs@FDA, application NDA020573 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020573)
• Camptosar (irinotecan hydrochloride)1996 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1996-06-14. Active ingredient: irinotecan hydrochloride. Sponsor: Pfizer Inc. Application NDA020571.FDA Drugs@FDA, application NDA020571 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020571)
• Crixivan (indinavir sulfate)1996 · FDA new drug approval · Merck & Co. headquarters, KenilworthNew drug approved by the FDA on 1996-03-13. Active ingredient: indinavir sulfate. Sponsor: Merck Sharp Dohme. Application NDA020685.FDA Drugs@FDA, application NDA020685 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020685)
• Denavir (penciclovir)1996 · FDA new drug approval · Mylan headquarters, CanonsburgNew drug approved by the FDA on 1996-09-24. Active ingredient: penciclovir. Sponsor: Mylan. Application NDA020629.FDA Drugs@FDA, application NDA020629 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020629)
• Differin (adapalene)1996 · FDA new drug approval · Galderma headquarters, ZugNew drug approved by the FDA on 1996-05-31. Active ingredient: adapalene. Sponsor: Galderma Labs Lp. Application NDA020338.FDA Drugs@FDA, application NDA020338 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020338)
• Diovan (valsartan)1996 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1996-12-23. Active ingredient: valsartan. Sponsor: Novartis. Application NDA020665.FDA Drugs@FDA, application NDA020665 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020665)
• Dostinex (cabergoline)1996 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1996-12-23. Active ingredient: cabergoline. Sponsor: Pfizer. Application NDA020664.FDA Drugs@FDA, application NDA020664 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020664)
• Gemzar (gemcitabine hydrochloride)1996 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1996-05-15. Active ingredient: gemcitabine hydrochloride. Sponsor: Lilly. Application NDA020509.FDA Drugs@FDA, application NDA020509 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020509)
• Glyset (miglitol)1996 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1996-12-18. Active ingredient: miglitol. Sponsor: Pfizer. Application NDA020682.FDA Drugs@FDA, application NDA020682 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020682)
• Humalog Kwikpen (insulin lispro recombinant)1996 · FDA new drug approval · Eli Lilly and Company headquarters, IndianapolisNew drug approved by the FDA on 1996-06-14. Active ingredient: insulin lispro recombinant. Sponsor: Lilly. Application BLA020563.FDA Drugs@FDA, application BLA020563 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020563)
• Hycamtin (topotecan hydrochloride)1996 · FDA new drug approval · Sandoz headquarters, BaselNew drug approved by the FDA on 1996-05-28. Active ingredient: topotecan hydrochloride. Sponsor: Sandoz. Application NDA020671.FDA Drugs@FDA, application NDA020671 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020671)
• Lipitor (atorvastatin calcium)1996 · FDA new drug approval · Upjohn headquarters, MichiganNew drug approved by the FDA on 1996-12-17. Active ingredient: atorvastatin calcium. Sponsor: Upjohn. Application NDA020702.FDA Drugs@FDA, application NDA020702 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020702)
• Mavik (trandolapril)1996 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1996-04-26. Active ingredient: trandolapril. Sponsor: Abbvie. Application NDA020528.FDA Drugs@FDA, application NDA020528 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020528)
• Maxipime (cefepime hydrochloride)1996 · FDA new drug approval · Hospira headquarters, Lake ForestNew drug approved by the FDA on 1996-01-18. Active ingredient: cefepime hydrochloride. Sponsor: Hospira Inc. Application NDA050679.FDA Drugs@FDA, application NDA050679 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050679)
• Merrem Iv (meropenem)1996 · FDA new drug approval · Pfizer headquarters, New York CityNew drug approved by the FDA on 1996-06-21. Active ingredient: meropenem. Sponsor: Pfizer. Application NDA050706.FDA Drugs@FDA, application NDA050706 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050706)
• Naropin (ropivacaine hydrochloride)1996 · FDA new drug approval · Fresenius Kabi headquarters, Bad Homburg vor der HöheNew drug approved by the FDA on 1996-09-24. Active ingredient: ropivacaine hydrochloride. Sponsor: Fresenius Kabi Usa. Application NDA020533.FDA Drugs@FDA, application NDA020533 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020533)
• Norvir (ritonavir)1996 · FDA new drug approval · AbbVie headquarters, North ChicagoNew drug approved by the FDA on 1996-03-01. Active ingredient: ritonavir. Sponsor: Abbvie. Application NDA020659.FDA Drugs@FDA, application NDA020659 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020659)
• Pataday Twice Daily Relief (olopatadine hydrochloride)1996 · FDA new drug approval · Alcon headquarters, GenevaNew drug approved by the FDA on 1996-12-18. Active ingredient: olopatadine hydrochloride. Sponsor: Alcon Labs Inc. Application NDA020688.FDA Drugs@FDA, application NDA020688 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020688)
• Remeron (mirtazapine)1996 · FDA new drug approval · Organon & Co. headquarters, OssNew drug approved by the FDA on 1996-06-14. Active ingredient: mirtazapine. Sponsor: Organon. Application NDA020415.FDA Drugs@FDA, application NDA020415 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020415)
• Stromectol (ivermectin)1996 · FDA new drug approval · Merck & Co. headquarters, KenilworthNew drug approved by the FDA on 1996-11-22. Active ingredient: ivermectin. Sponsor: Merck Sharp Dohme. Application NDA050742.FDA Drugs@FDA, application NDA050742 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050742)
• Taxotere (docetaxel)1996 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1996-05-14. Active ingredient: docetaxel. Sponsor: Sanofi Aventis Us. Application NDA020449.FDA Drugs@FDA, application NDA020449 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020449)
• Viramune (nevirapine)1996 · FDA new drug approval · Boehringer Ingelheim headquarters, Ingelheim am RheinNew drug approved by the FDA on 1996-06-21. Active ingredient: nevirapine. Sponsor: Boehringer Ingelheim. Application NDA020636.FDA Drugs@FDA, application NDA020636 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020636)
• Visipaque 270 (iodixanol)1996 · FDA new drug approval · GE HealthCare headquarters, Little ChalfontNew drug approved by the FDA on 1996-03-22. Active ingredient: iodixanol. Sponsor: Ge Healthcare. Application NDA020351.FDA Drugs@FDA, application NDA020351 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020351)
• Vistide (cidofovir)1996 · FDA new drug approval · Gilead Sciences headquarters, Foster CityNew drug approved by the FDA on 1996-06-26. Active ingredient: cidofovir. Sponsor: Gilead Sciences Inc. Application NDA020638.FDA Drugs@FDA, application NDA020638 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020638)
• Xalatan (latanoprost)1996 · FDA new drug approval · Upjohn headquarters, MichiganNew drug approved by the FDA on 1996-06-05. Active ingredient: latanoprost. Sponsor: Upjohn. Application NDA020597.FDA Drugs@FDA, application NDA020597 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020597)
• Zagam (sparfloxacin)1996 · FDA new drug approval · Mylan headquarters, CanonsburgNew drug approved by the FDA on 1996-12-19. Active ingredient: sparfloxacin. Sponsor: Mylan. Application NDA020677.FDA Drugs@FDA, application NDA020677 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020677)
• Zyflo (zileuton)1996 · FDA new drug approval · Chiesi Farmaceutici S.p.A. headquarters, ParmaNew drug approved by the FDA on 1996-12-09. Active ingredient: zileuton. Sponsor: Chiesi. Application NDA020471.FDA Drugs@FDA, application NDA020471 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020471)
• Zyprexa (olanzapine)1996 · FDA new drug approval · Cheplapharm Arzneimittel headquarters, GreifswaldNew drug approved by the FDA on 1996-09-30. Active ingredient: olanzapine. Sponsor: Cheplapharm. Application NDA020592.FDA Drugs@FDA, application NDA020592 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020592)
• Aldara (imiquimod)1997 · FDA new drug approval · Bausch & Lomb headquarters, RochesterNew drug approved by the FDA on 1997-02-27. Active ingredient: imiquimod. Sponsor: Bausch. Application NDA020723.FDA Drugs@FDA, application NDA020723 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020723)
• Avapro (irbesartan)1997 · FDA new drug approval · Sanofi headquarters, ParisNew drug approved by the FDA on 1997-09-30. Active ingredient: irbesartan. Sponsor: Sanofi Aventis Us. Application NDA020757.FDA Drugs@FDA, application NDA020757 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020757)
• Corlopam (fenoldopam mesylate)1997 · FDA new drug approval · Hospira headquarters, Lake ForestNew drug approved by the FDA on 1997-09-23. Active ingredient: fenoldopam mesylate. Sponsor: Hospira. Application NDA019922.FDA Drugs@FDA, application NDA019922 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019922)
• Emadine (emedastine difumarate)1997 · FDA new drug approval · Novartis headquarters, BaselNew drug approved by the FDA on 1997-12-29. Active ingredient: emedastine difumarate. Sponsor: Novartis. Application NDA020706.FDA Drugs@FDA, application NDA020706 (https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020706)

Pages: 1 2 3